Noninvasive measurement of central vascular pressures with arterial tonometry: Clinical revival of the pulse pressure waveform?

Mayo Clinic Proceedings

Volumn 85, Issue 5, 2010, Pages 460-472

  Nelson, Matthew R ^a   Stepanek, Jan ^a   Cevette, Michael ^a   Covalciuc, Michael ^a   Hurst, R Todd ^a   Tajik, A Jamil ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; EPROSARTAN; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDAPAMIDE; NEBIVOLOL; PERINDOPRIL; PLACEBO; RAMIPRIL; THIAZIDE DIURETIC AGENT; VALSARTAN; VASODILATOR AGENT;

ARTERIAL TONOMETRY; ARTERY; ATHEROSCLEROSIS; AUGMENTATION INDEX; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BLOOD VOLUME; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COHORT ANALYSIS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIAGNOSTIC VALUE; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; HEART ATRIUM FIBRILLATION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE MASS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LOW DRUG DOSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NON INVASIVE PROCEDURE; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PERIPHERAL VASCULAR DISEASE; PHYSICIAN; POSITIVE END EXPIRATORY PRESSURE; PULSE PRESSURE; PULSE WAVE; RADIAL ARTERY; REVIEW; RISK FACTOR; SLEEP APNEA SYNDROME; SLEEP DISORDERED BREATHING; SMOKING; SYSTOLIC BLOOD PRESSURE; TONOMETRY; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VASODILATATION;

EID: 77951721505     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/mcp.2009.0336     Document Type: Review

References (90)

1. O'Rourke MF, Seward JB. Central arterial pressure and arterial pressure pulse: new views entering the second century after Korotkov. Mayo Clin Proc. 2006;81(8):1057-1068.
2. Breasted JH. The Edwin Smith Surgical Papyrus. Vol 1. Chicago, IL: University of Chicago Press; 1930:105.
3. Acierno L. The History of Cardiology. 1 ed. Taylor and Francis; 1994:758.
4. Snellen HA. E.J. Marey and Cardiology: Physiologist and Pioneer of Technology (1830-1904). Rotterdam, The Netherlands: Kooyker Scientific Publications; 1980.
5. Cournand A, Ranges A. Catheterization of the right auricle in man. Proc Soc Exp Biol Med. 1941;46:462-466.
6. Kroeker EJ, Wood EH. Beat-to-beat alterations in relationship of simultaneously recorded central and peripheral arterial pressure pulses during Valsalva maneuver and prolonged expiration in man. J Appl Physiol. 1956;8(5):483-494.
7. Kroeker EJ, Wood EH. Comparison of simultaneously recorded central and peripheral arterial pressure pulses during rest, exercise and tilted position in man. Circ Res. 1955;3(6):623-632.
8. Roman MJ, Devereux RB, Kizer JR, et al. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study. Hypertension. 2007;50(1):197-203.
9. London GM, Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME. Arterial wave reflections and survival in end-stage renal failure. Hypertension. 2001;38(3):434-438. (Pubitemid 34225679)
10. Safar ME, Blacher J, Pannier B, et al. Central pulse pressure and mortality in end-stage renal disease. Hypertension. 2002;39(3):735-738. (Pubitemid 34252866)
11. Williams B, Lacy PS, Thom SM, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation. 2006;113(9):1213-1225. (Pubitemid 43754247)
12. Dahlof B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359(9311):995- 1003. (Pubitemid 34286536)
13. London GM, Asmar RG, O'Rourke MF, Safar ME. Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol. J Am Coll Cardiol. 2004;43(1):92-99. (Pubitemid 38045921)
14. O'Rourke MF, Nichols WW. Effect of ramipril on cardiovascular events in high-risk patients [letter]. N Engl J Med. 2000;343(1):64-65.
15. Sharman JE, Stowasser M, Fassett RG, Marwick TH, Franklin SS. Central blood pressure measurement may improve risk stratification. J Hum Hypertens. 2008;22:838-844.
16. McEniery CM, Yasmin, McDonnell B, et al. Central pressure: variability and impact of cardiovascular risk factors: the Anglo-Cardiff Collaborative Trial II. Hypertension. 2008;51(6):1476-1482.
17. Nakamura M, Sato K, Nagano M. Estimation of aortic systolic blood pressure in community-based screening: the relationship between clinical characteristics and peripheral to central blood pressure differences. J Hum Hypertens. 2005;19(3):251-253. (Pubitemid 40360942)
18. O'Rourke MF, Vlachopoulos C, Graham RM. Spurious systolic hypertension in youth. Vasc Med. 2000;5(3):141-145.
19. Chen CH, Nevo E, Fetics B, et al. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure: validation of generalized transfer function. Circulation. 1997;95(7):1827-1836. (Pubitemid 27164400)
20. Karamanoglu M, O'Rourke MF, Avolio AP, Kelly RP. An analysis of the relationship between central aortic and peripheral upper limb pressure waves in man. Eur Heart J. 1993;14(2):160-167. (Pubitemid 23089501)
21. Pauca AL, O'Rourke MF, Kon ND. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension. 2001;38(4):932-937.
22. Crilly M, Coch C, Clark H, Bruce M, Williams D. Repeatability of the measurement of augmentation index in the clinical assessment of arterial stiffness using radial applanation tonometry. Scand J Clin Lab Invest. 2007;67(4):413-422. (Pubitemid 46897615)
23. Crilly M, Coch C, Bruce M, Clark H, Williams D. Repeatability of central aortic blood pressures measured non-invasively using radial artery applanation tonometry and peripheral pulse wave analysis. Blood Press. 2007;16(4):262-269. (Pubitemid 47542950)
24. Adji A, Hirata K, O'Rourke MF. Clinical use of indices determined noninvasively from the radial and carotid pressure waveforms. Blood Press Monit. 2006;11(4):215-221. (Pubitemid 44084757)
25. McEniery CM. Yasmin, Hall IR, Qasem A, Wilkinson IB, Cockcroft JR. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol. 2005;46(9):1753-1760. (Pubitemid 41531635)
26. Spodick DH, Kumar S. Left ventricular ejection period. Measurement by atraumatic techniques: results in normal young men and comparison of methods of calculation. Am Heart J. 1968;76(1):70-73.
27. Yasmin, Brown MJ. Similarities and differences between augmentation index and pulse wave velocity in the assessment of arterial stiffness. QJM. 1999;92(10):595-600.
28. Wilkinson IB, Mohammad NH, Tyrrell S, et al. Heart rate dependency of pulse pressure amplification and arterial stiffness. Am J Hypertens. 2002;15(1, pt 1):24-30. (Pubitemid 34102268)
29. Zambanini A, Cunningham SL, Parker KH, Khir AW, McG Thom SA, Hughes AD. Wave-energy patterns in carotid, brachial, and radial arteries: a noninvasive approach using wave-intensity analysis. Am J Physiol Heart Circ Physiol. 2005;289(1):H270-H276. (Pubitemid 40934110)
30. Weber T, Auer J, O'Rourke MF, et al. Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation. 2004;109(2):184-189. (Pubitemid 38114137)
31. Lehmann ED, Hopkins KD, Rawesh A, et al. Relation between number of cardiovascular risk factors/events and noninvasive Doppler ultrasound assessments of aortic compliance. Hypertension. 1998;32(3):565-569. (Pubitemid 28429150)
32. Vaitkevicius PV, Fleg JL, Engel JH, et al. Effects of age and aerobic capacity on arterial stiffness in healthy adults. Circulation. 1993;88(4, pt 1):1456-1462.
33. Boutouyrie P, Tropeano AI, Asmar R, et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension. 2002;39(1):10-15. (Pubitemid 34098081)
34. Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation. 2002;106(16):2085-2090. (Pubitemid 35192814)
35. Kim YK. Impact of the metabolic syndrome and its components on pulse wave velocity. Korean J Intern Med. 2006;21(2):109-115. (Pubitemid 44340138)
36. Sutton-Tyrrell K, Najjar SS, Boudreau RM, et al. Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation. 2005;111(25):3384-3390. (Pubitemid 40923391)
37. Van Trijp MJ, Uiterwaal CS, Bos WJ, Oren A, Grobbee DE, Bots ML. Noninvasive arterial measurements of vascular damage in healthy young adults: relation to coronary heart disease risk. Ann Epidemiol. 2006;16(2):71-77. (Pubitemid 43197597)
38. Kampus P, Muda P, Kals J, et al. The relationship between inflammation and arterial stiffness in patients with essential hypertension. Int J Cardiol. 2006;112(1):46-51. (Pubitemid 44247175)
39. Casey DP, Pierce GL, Howe KS, Mering MC, Braith RW. Effect of resistance training on arterial wave reflection and brachial artery reactivity in normotensive postmenopausal women. Eur J Appl Physiol. 2007;100(4):403-408.
40. O'Rourke MF, Adji A. Basis for the use of central blood pressure measurement in office clinical practice. J Am Soc Hypertens. 2008;2(1):28-38.
41. Mahmud A, Feely J. Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension. Am J Hypertens. 2005;18(1):50-55. (Pubitemid 40187349)
42. Strauch B, Petrak O, Wichterle D, Zelinka T, Holaj R, Widimsky J Jr. Increased arterial wall stiffness in primary aldosteronism in comparison with essential hypertension. Am J Hypertens. 2006;19(9):909-914. (Pubitemid 46106987)
43. Pietri P, Vyssoulis G, Vlachopoulos C, et al. Relationship between lowgrade inflammation and arterial stiffness in patients with essential hypertension. J Hypertens. 2006;24(11):2231-2238. (Pubitemid 44611032)
44. Gedikli O, Ozturk S, Yilmaz H, et al. Relationship between arterial stiffness and myocardial damage in patients with newly diagnosed essential hypertension. Am J Hypertens. 2008;21(9):989-993.
45. Roman MJ, Devereux RB, Kizer JR, et al. Abstract 6203: central pulse pressure ≥50 mmHg predicts adverse cardiovascular outcome: the Strong Heart Study. Circulation. 2008;118:S-1157.
46. Tsang TS, Verzosa GC, Barnes ME, et al. Abstract 3163: central pulse pressure as a robust predictor of first atrial fibrillation: Study Of Atrial Fibrillation In High Risk Elderly (SAFFIHRE). Circulation. 2008;118:S-1106.
47. Weber T, Auer J, O'Rourke MF, et al. Increased arterial wave reflections predict severe cardiovascular events in patients undergoing percutaneous coronary interventions. Eur Heart J. 2005;26(24):2657-2663. (Pubitemid 41746688)
48. Heffernan KS, Jae SY, Wilund KR, Woods JA, Fernhall B. Racial differences in central blood pressure and vascular function in young men. Am J Physiol Heart Circ Physiol. 2008;295(6):H2380-H2387.
49. Bibbins-Domingo K, Pletcher MJ, Lin F, et al. Racial differences in incident heart failure among young adults. N Engl J Med. 2009;360(12):1179-1190.
50. Jamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359(23):2417-2428.
51. Weinsaft JW. Effect of ramipril on cardiovascular events in high-risk patients [letter]. N Engl J Med. 2000;343(1):64.
52. Kjeldsen SE, Dahlof B, Devereux RB, et al. Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy. JAMA. 2002;288(12):1491-1498.
53. Wing LM, Reid CM, Ryan P, et al. A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med. 2003;348(7):583-592. (Pubitemid 36204952)
54. Dart AM, Reid CM, McGrath B. Effects of ACE inhibitor therapy on derived central arterial waveforms in hypertension. Am J Hypertens. 2001;14(8, pt 1):804-810. (Pubitemid 32682249)
55. Klingbeil AU, John S, Schneider MP, Jacobi J, Weidinger G, Schmieder RE. AT1-receptor blockade improves augmentation index: a double-blind, randomized, controlled study. J Hypertens. 2002;20(12):2423-2428. (Pubitemid 36026855)
56. Morgan T, Lauri J, Bertram D, Anderson A. Effect of different antihypertensive drug classes on central aortic pressure. Am J Hypertens. 2004;17(2):118-123. (Pubitemid 38125127)
57. Dhakam Z, McEniery CM, Yasmin, Cockcroft JR, Brown MJ, Wilkinson IB. Atenolol and eprosartan: differential effects on central blood pressure and aortic pulse wave velocity. Am J Hypertens. 2006;19(2):214-219. (Pubitemid 43350177)
58. Jiang XJ, O'Rourke MF, Zhang YQ, He XY, Liu LS. Superior effect of an angiotensin-converting enzyme inhibitor over a diuretic for reducing aortic systolic pressure. J Hypertens. 2007;25(5):1095-1099.
59. Adji A, Hirata K, Hoegler S, O'Rourke MF. Noninvasive pulse waveform analysis in clinical trials: similarity of two methods for calculating aortic systolic pressure. Am J Hypertens. 2007;20(8):917-922. (Pubitemid 47176349)
60. Mahmud A, Feely J. Beta-blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection. Am J Hypertens. 2008;21(6):663-667. (Pubitemid 351733365)
61. Dahlof B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005;366(9489):895-906. (Pubitemid 41265663)
62. Devereux RB, Dahlof B, Gerdts E, et al. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial. Circulation. 2004;110(11):1456-1462. (Pubitemid 39238023)
63. Drager LF, Bortolotto LA, Figueiredo AC, Silva BC, Krieger EM, Lorenzi-Filho G. Obstructive sleep apnea, hypertension, and their interaction on arterial stiffness and heart remodeling. Chest. 2007;131(5):1379-1386. (Pubitemid 46762342)
64. Jelic S, Bartels MN, Mateika JH, Ngai P, DeMeersman RE, Basner RC. Arterial stiffness increases during obstructive sleep apneas. Sleep. 2002;25(8):850-855. (Pubitemid 35424527)
65. Noda A, Nakata S, Fukatsu H, et al. Aortic pressure augmentation as a marker of cardiovascular risk in obstructive sleep apnea syndrome. Hypertens Res. 2008;31(6):1109-1114.
66. Sharman JE, Fang ZY, Haluska B, Stowasser M, Prins JB, Marwick TH. Left ventricular mass in patients with type 2 diabetes is independently associated with central but not peripheral pulse pressure. Diabetes Care. 2005;28(4):937-939. (Pubitemid 40434502)
67. Hashimoto J, Imai Y, O'Rourke MF. Indices of pulse wave analysis are better predictors of left ventricular mass reduction than cuff pressure. Am J Hypertens. 2007;20(4):378-384. (Pubitemid 46441751)
68. Hashimoto J, Imai Y, O'Rourke MF. Monitoring of antihypertensive therapy for reduction in left ventricular mass. Am J Hypertens. 2007;20(11):1229-1233. (Pubitemid 47588822)
69. Abhayaratna WP, Barnes ME, O'Rourke MF, et al. Relation of arterial stiffness to left ventricular diastolic function and cardiovascular risk prediction in patients ≥65 years of age. Am J Cardiol. 2006;98(10):1387-1392.
70. Weber T, Auer J, O'Rourke MF, Punzengruber C, Kvas E, Eber B. Prolonged mechanical systole and increased arterial wave reflections in diastolic dysfunction. Heart. 2006;92(11):1616-1622. (Pubitemid 44629167)
71. Covic A, Haydar AA, Bhamra-Ariza P, Gusbeth-Tatomir P, Goldsmith DJ. Aortic pulse wave velocity and arterial wave reflections predict the extent and severity of coronary artery disease in chronic kidney disease patients. J Nephrol. 2005;18(4):388-396. (Pubitemid 41700101)
72. Lekakis JP, Ikonomidis I, Protogerou AD, et al. Arterial wave reflection is associated with severity of extracoronary atherosclerosis in patients with coronary artery disease. Eur J Cardiovasc Prev Rehabil. 2006;13(2):236-242. (Pubitemid 44097729)
73. Eldrup N, Sillesen H, Prescott E, Nordestgaard BG. Ankle brachial index, C-reactive protein, and central augmentation index to identify individuals with severe atherosclerosis. Eur Heart J. 2006;27(3):316-322. (Pubitemid 43100027)
74. Khaleghi M, Kullo IJ. Aortic augmentation index is associated with the ankle-brachial index: a community-based study. Atherosclerosis. 2007;195(2):248-253. (Pubitemid 350087952)
75. Qureshi G, Brown R, Salciccioli L, et al. Relationship between aortic atherosclerosis and non-invasive measures of arterial stiffness. Atherosclerosis. 2007;195(2):e190-e194.
76. Wilkinson IB, MacCallum H, Rooijmans DF, et al. Increased augmentation index and systolic stress in type 1 diabetes mellitus. QJM. 2000;93(7):441-448. (Pubitemid 30459922)
77. Westerbacka J, Leinonen E, Salonen JT, et al. Increased augmentation of central blood pressure is associated with increases in carotid intima-media thickness in type 2 diabetic patients. Diabetologia. 2005;48(8):1654-1662. (Pubitemid 41175520)
78. Sommerfield AJ, Wilkinson IB, Webb DJ, Frier BM. Vessel wall stiffness in type 1 diabetes and the central hemodynamic effects of acute hypoglycemia. Am J Physiol Endocrinol Metab. 2007;293(5):E1274-E1279.
79. Gordin D, Ronnback M, Forsblom C, Heikkila O, Saraheimo M, Groop PH. Acute hyperglycaemia rapidly increases arterial stiffness in young patients with type 1 diabetes. Diabetologia. 2007;50(9):1808-1814. (Pubitemid 47222850)
80. Henry RM, Kostense PJ, Spijkerman AM, et al. Arterial stiffness increases with deteriorating glucose tolerance status: the Hoorn Study. Circulation. 2003;107(16):2089-2095.
81. Schram MT, Henry RM, van Dijk RA, et al. Increased central artery stiffness in impaired glucose metabolism and type 2 diabetes: the Hoorn Study. Hypertension. 2004;43(2):176-181. (Pubitemid 38174170)
82. Sharman JE, McEniery CM, Dhakam ZR, Coombes JS, Wilkinson IB, Cockcroft JR. Pulse pressure amplification during exercise is significantly reduced with age and hypercholesterolemia. J Hypertens. 2007;25(6):1249-1254.
83. Wilkinson IB, Prasad K, Hall IR, et al. Increased central pulse pressure and augmentation index in subjects with hypercholesterolemia. J Am Coll Cardiol. 2002;39(6):1005-1011. (Pubitemid 34234123)
84. Aznaouridis K, Vlachopoulos C, Dima I, Ioakeimidis N, Stefanadis C. Triglyceride level is associated with wave reflections and arterial stiffness in apparently healthy middle-aged men. Heart. 2007;93(5):613-614. (Pubitemid 46707116)
85. Williams B, Lacy PS, Cruickshank JK, et al. Impact of statin therapy on central aortic pressures and hemodynamics: principal results of the Conduit Artery Function Evaluation-Lipid-Lowering Arm (CAFE-LLA) Study. Circulation. 2009;119(1):53-61.
86. Rehill N, Beck CR, Yeo KR, Yeo WW. The effect of chronic tobacco smoking on arterial stiffness. Br J Clin Pharmacol. 2006;61(6):767-773. (Pubitemid 43794808)
87. Mills NL, Miller JJ, Anand A, et al. Increased arterial stiffness in patients with chronic obstructive pulmonary disease: a mechanism for increased cardiovascular risk. Thorax. 2008;63(4):306-311. (Pubitemid 351497941)
88. Jatoi NA, Jerrard-Dunne P, Feely J, Mahmud A. Impact of smoking and smoking cessation on arterial stiffness and aortic wave reflection in hypertension. Hypertension. 2007;49(5):981-985. (Pubitemid 351664328)
89. O'Brien E, Waeber B, Parati G, Staessen J, Myers MG. Blood pressure measuring devices: recommendations of the European Society of Hypertension. BMJ. 2001;322(7285):531-536. (Pubitemid 32230920)
90. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7). National Heart, Lung, and Blood Institute Web site. http://www.nhlbi.nih.gov/guidelines/ hypertension. Accessed March 29, 2010.